Kadar Antibodi Anti-dsDNA dan Urine Monocyte Chemoattractant Protein-1 pada Nefritis Lupus
DOI:
https://doi.org/10.21776/ub.jkb.2012.027.02.8Abstract
ABSTRAK
Kata Kunci: Lupus  eritematosus  sistemik  (LES) merupakan  penyakit  autoimun  yang  ditandai  oleh  peradangan  kronis  dan  akut. Biomarker klasik untuk mendeteksi adanya penyakit LES adalah antibody anti-double stranded DNA (anti-dsDNA) dan urine Monocyte Chemoattractant Protein-1  (uMCP-1).  Penelitian ini dilakukan untuk mengkaji hubungan antara kedua biomarker tersebut dengan klasifikasi histopatologis nefritis lupus untuk mengganti biopsi ginjal dalam penentuan kelas histopatologi nefritis lupus.  Penelitian ini dilakukan selama 11 bulan  berupa studi observasional dengan pengambilan sampel darah dan urin untuk mengetahui kadar antibodi anti-dsDNA dan MCP-1, serta biopsi ginjal untuk menentukan kelas nefritis lupus berdasarkan klasifikasi WHO tahun 1982.  Data hasil penelitian menunjukkan tidak ada perbedaan yang signifikan (p=0,208>α) antara mean rank kadar anti-dsDNA pada kelompok kontrol dan kelompok kasus,begitu pula dengan hasil perbandingan mean rank kadar uMCP-1 (p=0,247>α).  Uji korelasi Spearman's rho,menunjukkan hubungan signifikan kadar anti-dsDNA dan kadar uMCP-1 (r = 0,861; p<0,001). Dapat disimpulkan bahwa tidak terdapat perbedaan kadar biomarker antibodi anti-dsDNA dan urine MCP1 pada kejadian nefritis lupus dan klasifikasi histopatologi nefritis lupus, namun terdapat hubungan yang sangat erat antara kadar biomarker antibodi anti-dsDNA dengan kadar urine MCP-1. Nilai sensitifitas kadar anti-dsDNA dan uMCP-1  lebih rendah yaitu 20% – 40% dibandingkan dengan nilai spesifisitasnya, yaitu 50% – 83,33%.
Kata Kunci: Anti-dsDNA, uMCP-1, klasifikasi histopatologi, nefritis  lupus
Downloads
References
DAFTAR PUSTAKA
Bawazier LA, Dharmeizar, dan Markum HMS. Nefritis Lupus. Di dalam: Sudoyo WA (Ed). Buku Ajar Ilmu Penyakit Dalam edisi V. Jakarta: InternaPublishing; 2007.
Dooley MA. Clinical and Laboratory Features of Lupus Nephritis. In: Wallace DJ (Ed). Dubois' Lupus Erythematosus 7th edition. Philadelphia: Lippincott Williams & Wilkins; 2007; p. 1112-1130.
Rus V, Maury EE, and Hochberg MC. Epidemiology of Systemic Lupus Erythematosus. In: Wallace DJ (Ed). Dubois' Lupus Erythematosus 7th edition. Philadelphia: Lippincott Williams & Wilkins; 2007; p. 34-44.
Tucci M, Barnes EV, Sobel ES, et al. Strong Association of a Functional Polymorphism in the Monocyte Chemoattractant Protein 1 Promoter Gene with Lupus Nephritis. Arthritis and Rheumatism. 2004; 50(6): 1842–1849.
Li Y, Lee PY , Sobel ES, et al. Increased Expression of FcγRI/CD64 on Circulating Monocytes Parallels Ongoing Inflammation and Nephritis in Lupus. Arthritis Research & Therapy. 2009; 11(1): R6.
Brent LH and Hamed FA. Lupus Nephritis. In: James K (Ed). Lupus Erythematosus 12th edition. Washington: Lippincott Williams & Wilkins; 2008; p. 849-867.
Jaekell HP, Trabandt A, Grobe N, and Werle E. Anti-Dsdna Antibody Subtypes and Anti-C1q Antibodies: Toward a more Reliable Diagnosis and Monitoring of Systemic Lupus Erythematosus and Lupus Nephritis. Lupus. 2006; 15(6): 335-345.
Manson JJ, Ma A, Rogers P, et al. Relationship
between Anti-dsDNA, Anti-Nucleosome and Anti-Alpha-Actinin Antibodies and Markers of Renal Disease Inpatients with Lupus Nephritis: A Prospective Longitudinal Study. Arthritis Research and Theraphy. 2009; 11(5): R154.
Marks SD, Williams SJ, Tullus K, and Sebire NJ. Glomerular Expression of Monocyte Chemoattractant Protein-1 is Predictive of Poor Renal Prognosis in Paediatric Lupus Nephritis. Nephrology Dialysis Transplantation. 2008; 23(11): 3521–3526.
Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY , and Nagaraja HN. Urinary Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity. Journal of the American Society of Nephrology. 2005; 16(2): 467-473.
Marks SD, Shah V, Pilkington C, and Tullus K. Urinary Monocyte Chemoattractant Protein-1 Correlates with Disease Activity in Lupus Nephritis. 2010; 25(11): 2283-2288.
Mok CC. Biomarker for Lupus Nephritis: A Critical
Apparai sal . Journal of Biomedi c ine and Biotechnology. 2010; 2010: 638413.
Lahita RG, Tsokos G, Buyon JP, and Koike T. Systemic Lupus Erythematosus. 4th edition. London: Academic Press; 2004.
Wal lace DJ and Hahn BH. Dubois' Lupus Erythematosus. 4th edition. Philadelphia: Lippincott William & Wilkins; 2007; p. 93-104.
Sastroasmoro S dan Ismael S. Dasar-dasar Metodelogi Penelitian Klinis. Edisi 2. Jakarta: Sagung Seto; 2002; hal. 137-141.
Seligman VA, Lum RF, Olson JL, Li H, and Criswell LA. Demographic Differences in the Outcome of SLE Nephritis: A Retrospective Analysis. American Journal of Medicine. 2002; 112(9): 726-729.
Mortensen ES and Rekvig OP. Nephritogenic Potential of Ant i -DNA Ant ibodies against Necrot ic Nucleosomes. Journal of the American Society of Nephrology. 2009; 20(4): 696–704.
Amoura Z, Koutouzov S, Chabre H, et al. Presence of Antinucleosome Autoantibodies in a Restricted Set of Connective Tissue Diseases: Antinucleosome Antibodies of the Igg3 Subclass are Markers of Renal Pathogenicity in Systemic Lupus Erythematosus. Arthritis and Rheumatism. 2000; 43(1): 76-84.
Peutz-Koostra CJ, de Heer E, Hoedemaeker PJ, Abrass CK, and Bruijn JA. Lupus Nephritis: Lessons from Experimental Animal Models. Journal of Laboratory and Clinical Medicine. 2001; 137(4): 244-260.
Du Hui, Chen Min, Zhang Ying, Zhao Ming-hui, Wang Hai-Yan. Cross-Reaction of Anti-DNA Autoantibodies With Membrane Proteins of Human Glomerular Mesangial Cells in Sera from Patients with Lupus Nephritis. Clinical and Experimental Immunology. 2006; 145(1): 21–27.
Rekvig OP, Kalaaji M, and Nossent H. Anti-DNA
Antibody Subpopulations and Lupus Nephritis. Autoimmunity Reviews. 2004; 3(2): 1–6.
Kim HL, Lee DS, Yang SH et al. The Polymorphism of Monocyte Chemoattractant Protein-1 is Associated with the Renal Disease of SLE. American Journal of Kidney Disease. 2002; 40(6): 1146-1152.
Tian S, Li J, Wang L, et al. Urinary Levels of RANTES nd
M-CSF are Predictor of Lupus Nephritis Flare. Inflammation Research. 2007; 56(7): 304-310.
Rahman A and Isenberg DA. Systemsic Lupus Erythematosus. The New England Journal of Medicine. 2008; 358(9): 929-939.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
